SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-061313
Filing Date
2020-05-14
Accepted
2020-05-14 11:11:02
Documents
47
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2014617-1_10q.htm 10-Q 363493
2 EXHIBIT 31.1 tm2014617d1_ex31-1.htm EX-31.1 10108
3 EXHIBIT 31.2 tm2014617d1_ex31-2.htm EX-31.2 10117
4 EXHIBIT 32.1 tm2014617d1_ex32-1.htm EX-32.1 5728
5 EXHIBIT 99.1 tm2014617d1_ex99-1.htm EX-99.1 52954
12 GRAPHIC tm2014617-1_10qimg001.jpg GRAPHIC 11414
13 GRAPHIC logo.jpg GRAPHIC 1982
  Complete submission text file 0001104659-20-061313.txt   2498413

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fencf-20200331.xml EX-101.INS 542798
7 XBRL TAXONOMY EXTENSION SCHEMA fencf-20200331.xsd EX-101.SCH 26331
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fencf-20200331_cal.xml EX-101.CAL 21952
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fencf-20200331_def.xml EX-101.DEF 79529
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20200331_lab.xml EX-101.LAB 181876
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20200331_pre.xml EX-101.PRE 160414
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 20876189
SIC: 2836 Biological Products, (No Diagnostic Substances)